Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1007 per EA under NDC 62332001671. Its NADAC has been published 490 times since Feb 8, 2017.
The High Outlier badge above means this manufacturer's average price in the Metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001671
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA079067On Market Since
12/1/2016
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 490 times since Feb 8, 2017, and over the history we have for it it has declined 59.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1007 per EA |
|---|---|
| All-time high | $0.2485 (Feb 15, 2017) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1096 |
| 52-week low | $0.0623 |
| Median price | $0.1250 |
| Average price | $0.1399 |
| Largest weekly change | +36.9% (May 22, 2019) |
| Weeks tracked | 490 |
| Tracking since | Feb 8, 2017 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1007 per EA (NDC 62332001671), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 59.5%. It has been tracked across 490 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Feb 8, 2017, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.2485 (Feb 15, 2017), with a median of $0.1250 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METRONIDAZOLE 250 MG TABLET, is $0.0970 per EA — about 4% below METRONIDAZOLE 250 MG TABLET.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 62332001671) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification